Profile: Nupathe Inc (PATH.OQ)
10 Dec 2013
NuPathe Inc. (NuPathe), incorporated on January 7, 2005, is a specialty pharmaceutical company focused on the development and commercialization of therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders. The Company’s product candidate, Zelrix, is a single-use patch applied to the arm or thigh for the treatment of migraine.
Zelrix delivers sumatriptan through the skin in a controlled manner using its SmartRelief technology. Sumatriptan is available in oral, nasal and injectable formulations. The Company has two product candidates in preclinical development, which includes NP201 and NP202.
SUITE 300, 7 GREAT VALLEY PARKWA
MALVERN PA 19355